{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:56:21Z","timestamp":1769946981380,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.euo.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T05:09:36Z","timestamp":1586754576000},"page":"259-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["COVID-19 and Bacillus Calmette-Gu\u00e9rin: What is the Link?"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2678-2664","authenticated-orcid":false,"given":"Paul K.","family":"Hegarty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Sfakianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6995-246X","authenticated-orcid":false,"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5990-6470","authenticated-orcid":false,"given":"Andrew R.","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-9928","authenticated-orcid":false,"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2020.04.001_bib0005","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2020.04.001_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/iai.5.4.499-504.1972","article-title":"Correlation of increased metabolic activity, resistance to infection, enhanced phagocytosis, and inhibition of bacterial growth by macrophages from Listeria- and BCG-infected mice","volume":"5","author":"Ratzan","year":"1972","journal-title":"Infect Immun"},{"key":"10.1016\/j.euo.2020.04.001_bib0015","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euo.2020.04.001_bib0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.euo.2020.04.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.euo.2020.04.001_bib0030","doi-asserted-by":"crossref","unstructured":"Daza J., Charap A., Wiklund P.N., Sfakianos J.P. Role of the innate immune system in the development, progression, and therapeutic response of bladder cancer. Eur Urol Focus. In press. https:\/\/doi.org\/10.1016\/j.euf.2020.02.013.","DOI":"10.1016\/j.euf.2020.02.013"},{"key":"10.1016\/j.euo.2020.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.euo.2020.04.001_bib0040","unstructured":"European Centre for Disease Prevention and Control. Distribution of COVID-19 cases. www.ecdc.europa.eu\/en\/geographical-distribution-2019-ncov-cases."},{"key":"10.1016\/j.euo.2020.04.001_bib0045","unstructured":"Worldometer. Countries in the world by population (2020). www.worldometers.info\/world-population\/population-by-country."},{"key":"10.1016\/j.euo.2020.04.001_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.euo.2020.04.001_bib0055","author":"Bladder Cancer Advocacy Network"},{"key":"10.1016\/j.euo.2020.04.001_bib0060","doi-asserted-by":"crossref","unstructured":"Ficarra V., Novara G., Abrate A., et al. Urology practice during COVID-19 pandemic. Minerva Urol Nefrol. In press. https:\/\/doi.org\/10.23736\/S0393-2249.20.03846-1.","DOI":"10.23736\/S0393-2249.20.03846-1"},{"key":"10.1016\/j.euo.2020.04.001_bib0065","unstructured":"Babjuk M., Burger M., Comp\u00e9rat E., et al. EAU guidelines on non\u2013muscle-invasive bladder cancer. European Association of Urology. https:\/\/uroweb.org\/guideline\/non-muscle-invasive-bladder-cancer."},{"key":"10.1016\/j.euo.2020.04.001_bib0070","first-page":"145","article-title":"Intravesical therapy for non-muscle invasive bladder cancer\u2014current and future options in the age of bacillus Calmette-Guerin Shortage","volume":"21","author":"Golla","year":"2019","journal-title":"Rev Urol"},{"key":"10.1016\/j.euo.2020.04.001_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.euo.2020.02.006","article-title":"Evidence-based assessment of current and emerging bladder-sparing therapies for non\u2013muscle-invasive bladder cancer after bacillus Calmette-Guerin therapy: a systematic review and meta-analysis","volume":"3","author":"Kamat","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2020.04.001_bib0080","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.euo.2018.08.032","article-title":"Chemoablation with intensive intravesical mitomycin C treatment: a new approach for non\u2013muscle-invasive bladder cancer","volume":"2","author":"Racioppi","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2020.04.001_bib0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.euo.2019.01.002","article-title":"Effect of immunotherapy on local treatment of genitourinary malignancies","volume":"2","author":"Pignot","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2020.04.001_bib0090","unstructured":"Brooks N., Nagaraju S., Matulay Y., Han X.Y., Kamat A.M. Bacille Calmette-Gu\u00e9rin retains clinically relevant viability for up to 72 hours after reconstitution: implications for clinical practice in times of shortage. Eur Urol Oncol. In press."}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931120300493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931120300493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:45:28Z","timestamp":1762875928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931120300493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2588931120300493"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2020.04.001","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and Bacillus Calmette-Gu\u00e9rin: What is the Link?","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}